Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
206 articles
New research reveals how aggressive T cell lymphomas exploit the same pathways that normally activate healthy immune responses.
Ixekizumab demonstrated remarkable efficacy in treating children with juvenile arthritis, offering hope for better outcomes.
New study shows preventive treatment can stop autoimmune arthritis before it starts in vulnerable populations.
Historical analysis reveals how colchicum has remained a cornerstone gout treatment for over 2,000 years of medical practice.
Systematic uric acid monitoring and treatment achieved 64% better remission rates than waiting for symptoms to guide therapy.
New AI tool provides personalized, accessible information for lupus patients, improving disease understanding and care.
48-week trial shows biological drugs don't outperform standard treatment for patient-reported outcomes in early rheumatoid arthritis.
Updated EULAR recommendations provide evidence-based strategies for managing rheumatoid arthritis using synthetic and biologic medications.
Swedish study finds JAK inhibitors raise keratinocyte cancer risk by 39% compared to TNF inhibitors in RA patients.
Researchers develop breakthrough mouse model for calcium crystal arthritis, opening new paths for treatment development.
A 12-week study shows an app combining exercise, education, and gamification cut disease activity scores by 30% in spinal arthritis patients.
RESIST score identifies high-risk systemic sclerosis patients who may benefit from intensive therapy to prevent early mortality.
